Plasma metabolome analysis of patients with major depressive disorder

ConclusionThese results suggest that plasma PEA level could be a candidate biomarker of MDD in the clinical setting. Further studies comparing MDD and mentally healthy controls are needed to confirm the utility of PEA as a biomarker for depression.

Source: Psychiatry and Clinical Neurosciences - January 1, 2018 Category: Neuroscience Authors: Noriyuki Kawamura, Kosaku Shinoda, Hajime Sato, Kazunori Sasaki, Makoto Suzuki, Kumi Yamaki, Tamaki Fujimori, Hiroyuki Yamamoto, Douglas Osei ‐Hyiaman, Yoshiaki Ohashi Tags: Regular Article Source Type: research